Product Commercialization

Expand into global markets faster with culturally relevant and compliant messaging. Choose centralized content solutions that ensure native-level localized translation, meet varied regulatory requirements on a region-by-region basis, and increase your speed to global launch.

Get in Touch
Person using iPad to analyze metrics

Comprehensive Support for Product Launches and Commercialization Plans

By partnering with TransPerfect, your team will increase preparation efficiency and shorten time to launch. Discover our complete suite of global product launch solutions.

    Digital Marketing

    Obtain strategic guidance on your omnichannel digital marketing efforts and website localization with our TPT Digital solution. Drive visibility to global marketing campaigns and create targeted messaging for your commercialization plan based on the customer journey.

    Learn More

    Translation Services

    We offer powerful technology to enable faster, more accurate translations of your product launch collateral such as app, website, brochure, and e-learning materials. TransPerfect’s GlobalLink TMS automates manual steps, drives consistency through central TMs and linguistic assets, incorporates MT workflows, and offers real-time reporting for greater visibility and control.

    Learn More

    Social Listening

    Meet with experts to review keyword requirements, search terms, and translations. TransPerfect centralizes the review of literature and streamlines the monitoring of all major social channels to understand the global sentiment around your brand.

    Learn More

    Multicultural Marketing Consulting

    Work with TransPerfect’s cultural consultants to identify your target market, how to best adapt existing marketing content, and create original content and materials that will produce the desired results.

    Learn More

    Trusted by Life Sciences Organizations Big and Small

    With TransPerfect’s support, Novartis, Pfizer, and Merck have created an average of more than $5M in savings. Partnering with TransPerfect has significantly reduced their product localization costs and made it possible for their products to launch up to 50% faster than the competition.

    Novartis
    Pfizer logo
    Merck
    Get a Free Consult ›

    Better Product Commercialization Launches by the Numbers

    30 %

    Faster Product Launch Times

    100 %

    Regulatory Compliance

    $ 5 M

    Average Saved by Novartis, Pfizer, and Merck in Product Localization

    Ready to accelerate your product launch and commercialization?

    Get in Touch ›

    News and Thought Leadership

    View industry insights from our experts. We have the experience and solutions you need to navigate life sciences complexities and bring breakthroughs from lab to launch.

    The 5-Step AI Readiness Checklist for Medical Device Manufacturers

    Only one in four manufacturers using process AI say it's meeting expectations. The gap between those results and the rest comes down to preparation. This checklist is built from patterns shared by manufacturers that are seeing results, along with the gaps most commonly found among those that aren't. ...

    The 5-Step AI Readiness Checklist for Medical Device Manufacturers
    Webinar

    XTalks | How MI, PV & Regulatory Collaborate on Signals, Labeling, Crisis Response and AI

    Medical Information (MI), Pharmacovigilance (PV) and Regulatory Affairs (RA) each play distinct but deeply interconnected roles in ensuring that therapeutics are safe, accurately labeled and compliantly communicated to healthcare professionals and patients. Yet in practice, the ...
    Event

    C3 Summit 2026 - San Francisco

    Conversations on Clinical Content, C3 Summit is part of a series of events hosted by TransPerfect Life Sciences featuring sessions with expert panels discussing present challenges, strategies, and innovations, as well as insights into future advancements, from R&D to ...
    Webinar

    LifeSci Talks COA Series | Nothing Remains the Same: Why Measures Have to Evolve

    In this episode of LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences, sits down with RJ Wirth, CEO and Consulting Psychometrician at Vector Psychometric Group, to talk about why the measures we rely on are living things rather than fixed artifacts. ...
    Blog

    Regulatory Considerations for Paper COA Translations | What You Need to Know

    Collecting data for a global clinical trial on paper COAs or managing a mixed-mode study that combines both paper and electronic formats means satisfying multiple regulatory bodies before a single patient enrolls. None of these entities operate on the same timeline or...
    Blog

    When "How Does the Patient Feel?" Became a Regulatory Question

    For decades, clinical trials were built around things you could measure with a machine: tumor shrinkage on a scan, laboratory values, and disease progression. These hard, objective endpoints were the backbone of drug approval. The patient's own account of how they felt,...
    Webinar

    XTalks | eCOA: Has It Lived Up to the Promise? A Realistic Assessment for Today's Trials

    Despite two decades of technological advancement, the debate between paper and electronic clinical outcome assessments (eCOA) remains unresolved. This webinar revisits the assumptions that continue to shape data collection strategies and examines whether current practice reflects ...